Delivering safe, effective bio/pharmaceuticals demands that every component of your manufacturing process meets the highest standards. This begins with raw materials. Contaminated or non-compliant inputs can cause costly production delays, regulatory setbacks, or worse, compromise patient safety. Early, reliable testing of raw materials is critical to mitigate these risks.

The Eurofins BioPharma Product Testing (BPT) network of laboratories offers comprehensive raw materials and excipient testing services designed to protect your manufacturing processes and ensure the highest quality outcomes. Our global facilities combine extensive chemistry expertise with state-of-the-art instrumentation, delivering dependable results at every phase of bio/pharmaceutical production.

We provide a full range of services, including compendial analysis compliant with USP, Ph. Eur., JP, and other global standards, as well as non-compendial testing for materials not covered by pharmacopoeias. Our capabilities include residual solvents testing, microbial limits testing, elemental analysis, trace metals testing, pharmaceutical water testing, and assessment of thermodynamic properties.

Supporting biologics, gene therapies, and cell therapies, our teams understand the unique complexity of these advanced manufacturing processes. Non-monographed materials, diverse excipients, and evolving production technologies demand the kind of tailored solutions we have become known for.

Our flexible, client-centred approach ensures that testing is aligned with your regulatory strategy, project timelines, and material specifications. Whether you are preparing for IND, BLA submissions or supporting commercial manufacture, the Eurofins BPT network provides the responsiveness in raw materials testing and the confidence you need to move forward.